GRC Stock Analysis: Gorman-Rupp | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 1.967m USD | 12M Return: 60.4% | US3830821043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.1M
EPS Trend: 98.6%
Qual. Beats: 0
Rev. Trend: 94.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Gorman-Rupp Company (NYSE: GRC) is a U.S.-based manufacturer of pumps and pump systems, serving both domestic and international markets. Founded in 1933 and headquartered in Mansfield, Ohio, the company has been public since 1992 and operates within the Industrial Machinery & Components sub-industry. Its product portfolio spans a wide range of pump types, including self-priming centrifugal, standard centrifugal, magnetic drive, axial and mixed flow, vertical turbine line shaft, submersible, high-pressure booster, rotary gear, rotary vein, diaphragm, bellows, and oscillating pumps.
The companys pumps are deployed across a diversified set of end markets - water and wastewater, construction, dewatering, industrial, petroleum, chemical processing, OEM, agriculture, fire suppression, HVAC, and military applications - providing exposure to both cyclical sectors like construction and more stable, infrastructure-linked demand from municipal water and wastewater projects. Gorman-Rupp sells through a multi-channel distribution network that includes independent distributors, manufacturers representatives, third-party distributor catalogs, direct sales, retailers, and e-commerce, a structure typical of industrial equipment makers that rely on broad geographic and application coverage rather than a single go-to-market model.
- Federal infrastructure spending lifts water and wastewater pump orders
- Steel and copper cost inflation pressures pump manufacturing margins
- Military and defense pump contracts strengthen backlog growth
| Net Income: 62.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 4.14 > 1.0 |
| NWC/Revenue: 22.75% < 20% (prev 19.98%; Δ 2.77% < -1%) |
| CFO/TA 0.14 > 3% & CFO 119.8m > Net Income 62.4m |
| Net Debt (231.4m) to EBITDA (130.0m): 1.78 < 3 |
| Current Ratio: 2.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.4m) vs 12m ago 0.37% < -2% |
| Gross Margin: 30.56% > 18% (prev 30.90%; Δ -0.34% > 0.5%) |
| Asset Turnover: 81.24% > 50% (prev 78.19%; Δ 3.05% > 0%) |
| Interest Coverage Ratio: 4.91 > 6 (EBIT TTM 102.2m / Interest Expense TTM 20.8m) |
| A: 0.18 (Total Current Assets 248.1m - Total Current Liabilities 88.4m) / Total Assets 866.5m |
| B: 0.51 (Retained Earnings 446.1m / Total Assets 866.5m) |
| C: 0.12 (EBIT TTM 102.2m / Avg Total Assets 864.1m) |
| D: 1.04 (Book Value of Equity 441.4m / Total Liabilities 425.0m) |
| Altman-Z'' = 4.77 = AA |
| DSRI: 1.05 (Receivables 107.8m/98.7m, Revenue 702.1m/673.9m) |
| GMI: 1.01 (GM 30.90% / 30.56%) |
| AQI: 0.97 (AQ_t 0.56 / AQ_t-1 0.58) |
| SGI: 1.04 (Revenue 702.1m / 673.9m) |
| TATA: -0.07 (NI 62.4m - CFO 119.8m) / TA 866.5m) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 73.04 with a total of 137,382 shares traded. Over the past week, the price has changed by -2.78%, over one month by -3.25%, over three months by -6.22% and over the past year by +60.44%.
Current recommended Stop Loss: 69.90 (which is 4.3% or 1.3 ATR below the current price).
Gorman-Rupp has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy GRC.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 80.7 | 10.4% |
P/E Trailing = 31.6936
P/E Forward = 23.9808
P/S = 2.8018
P/B = 4.4626
P/EG = 1.8449
Revenue TTM = 702.1m USD
EBIT TTM = 102.2m USD
EBITDA TTM = 130.0m USD
Long Term Debt = 275.0m USD (from longTermDebt, last quarter)
Short Term Debt = 24.6m USD (from shortTermDebt, last fiscal year)
Debt = 275.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 231.4m USD (calculated: Debt 275.0m - CCE 43.6m)
Enterprise Value = 2.20b USD (1.97b + Debt 275.0m - CCE 43.6m)
Interest Coverage Ratio = 4.91 (Ebit TTM 102.2m / Interest Expense TTM 20.8m)
EV/FCF = 20.28x (Enterprise Value 2.20b / FCF TTM 108.4m)
FCF Yield = 4.93% (FCF TTM 108.4m / Enterprise Value 2.20b)
FCF Margin = 15.44% (FCF TTM 108.4m / Revenue TTM 702.1m)
Net Margin = 8.88% (Net Income TTM 62.4m / Revenue TTM 702.1m)
Gross Margin = 30.56% ((Revenue TTM 702.1m - Cost of Revenue TTM 487.5m) / Revenue TTM)
Gross Margin QoQ = 34.23% (prev 30.74%)
Tobins Q-Ratio = 2.54 (Enterprise Value 2.20b / Total Assets 866.5m)
Interest Expense / Debt = 7.58% (Interest Expense 20.8m / Debt 275.0m)
Taxrate = 22.89% (18.5m / 80.9m)
NOPAT = 78.8m (EBIT 102.2m * (1 - 22.89%))
Current Ratio = 2.81 (Total Current Assets 248.1m / Total Current Liabilities 88.4m)
Debt / Equity = 0.62 (Debt 275.0m / totalStockholderEquity, last quarter 441.4m)
Debt / EBITDA = 1.78 (Net Debt 231.4m / EBITDA 130.0m)
Debt / FCF = 2.13 (Net Debt 231.4m / FCF TTM 108.4m)
Total Stockholder Equity = 421.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.22% (Net Income 62.4m / Total Assets 866.5m)
RoE = 14.79% (Net Income TTM 62.4m / Total Stockholder Equity 421.7m)
RoCE = 14.67% (EBIT 102.2m / Capital Employed (Equity 421.7m + L.T.Debt 275.0m))
RoIC = 10.27% (NOPAT 78.8m / Invested Capital 767.5m)
WACC = 8.87% (E(1.97b)/V(2.24b) * Re(9.29%) + D(275.0m)/V(2.24b) * Rd(7.58%) * (1-Tc(0.23)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.94 | Cagr: 0.29%
[DCF] Terminal Value 76.31% ; FCFF base≈93.9m ; Y1≈107.6m ; Y5≈158.4m
[DCF] Fair Price = 73.99 (EV 2.19b - Net Debt 231.4m = Equity 1.95b / Shares 26.4m; r=8.87% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.62 | EPS CAGR: 29.63% | SUE: 0.60 | # QB: 0
Revenue Correlation: 94.20 | Revenue CAGR: 2.69% | SUE: -0.68 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.70 | Chg30d=+13.44% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=2.81 | Chg30d=+6.71% | Revisions=+50% | GrowthEPS=+31.3% | GrowthRev=+6.1%
EPS next Year (2027-12-31): EPS=3.16 | Chg30d=+5.56% | Revisions=+50% | GrowthEPS=+12.6% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: +73% (up=8, down=0)